(Q422418)

sulpiride (English)

3 October 2016

C₁₅H₂₃N₃O₄S

1 reference

sulpiride (English)

19 November 2016

CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC

1 reference

sulpiride (English)

World Health Organisation international non-proprietary name

19 November 2016

sulpiride (English)

1 reference

sulpiride (English)

significant drug interaction

3 October 2016

amiodarone

1 reference

High-priority drug–drug interactions for use in electronic health records

anagrelide

1 reference

High-priority drug–drug interactions for use in electronic health records

arsenic trioxide

1 reference

High-priority drug–drug interactions for use in electronic health records

astemizole

1 reference

High-priority drug–drug interactions for use in electronic health records

azithromycin

1 reference

High-priority drug–drug interactions for use in electronic health records

bepridil

1 reference

High-priority drug–drug interactions for use in electronic health records

chloroquine

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

cisapride

1 reference

High-priority drug–drug interactions for use in electronic health records

(RS)-citalopram

1 reference

High-priority drug–drug interactions for use in electronic health records

clarithromycin

1 reference

High-priority drug–drug interactions for use in electronic health records

cocaine

1 reference

High-priority drug–drug interactions for use in electronic health records

disopyramide

1 reference

High-priority drug–drug interactions for use in electronic health records

dofetilide

1 reference

High-priority drug–drug interactions for use in electronic health records

domperidone

1 reference

High-priority drug–drug interactions for use in electronic health records

dronedarone

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

erythromycin

1 reference

High-priority drug–drug interactions for use in electronic health records

escitalopram

1 reference

High-priority drug–drug interactions for use in electronic health records

flecainide

1 reference

High-priority drug–drug interactions for use in electronic health records

halofantrine

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

ibutilide

1 reference

High-priority drug–drug interactions for use in electronic health records

mesoridazine

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

reference URL

https://webcache.googleusercontent.com/search?q=cache:ePkp6V4KihIJ:https://bnf.nice.org.uk/interaction/methadone.html+&cd=17&hl=en&ct=clnk&gl=jo&client=firefox-b-d

moxifloxacin

1 reference

High-priority drug–drug interactions for use in electronic health records

ondansetron

1 reference

High-priority drug–drug interactions for use in electronic health records

pentamidine

1 reference

High-priority drug–drug interactions for use in electronic health records

pimozide

1 reference

High-priority drug–drug interactions for use in electronic health records

probucol

1 reference

High-priority drug–drug interactions for use in electronic health records

procainamide

1 reference

High-priority drug–drug interactions for use in electronic health records

quinidine

1 reference

High-priority drug–drug interactions for use in electronic health records

sevoflurane

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

sparfloxacin

1 reference

High-priority drug–drug interactions for use in electronic health records

terfenadine

1 reference

High-priority drug–drug interactions for use in electronic health records

thioridazine

1 reference

High-priority drug–drug interactions for use in electronic health records

dronedarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ondansetron

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiodarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

disopyramide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toremifene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

anagrelide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

erythromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clarithromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vandetanib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

crizotinib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pasireotide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paliperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

risperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tetrabenazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ivabradine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pentamidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mefloquine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

domperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fingolimod

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apomorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cabergoline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Quinagolide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paliperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ropinirol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pramipexole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bromocriptine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pergolide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

risperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(E/Z)-doxepin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(−)-selegiline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(6S)-rotigotine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levodopa

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apomorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toxic encephalopathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ondansetron

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiodarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

disopyramide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toremifene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

anagrelide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pentamidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

erythromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clarithromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mefloquine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

domperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fingolimod

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vandetanib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

crizotinib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pasireotide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ivabradine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paliperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

risperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(E/Z)-doxepin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(E/Z)-doxepin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tetrabenazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

extrapyramidal symptoms

1 reference

A reference set of clinically relevant adverse drug-drug interactions

encephalopathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dyskinesia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

asthenia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

brain injury

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

1 reference

17 August 2016

Carbonic anhydrase 12

subject has role

enzyme inhibitor

1 reference

17 August 2016

1 reference

17 August 2016

1 reference

17 August 2016

1 reference

17 August 2016

1 reference

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

D013469

second-generation antidepressive agents

15 March 2018

1 reference

InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)

Medical Subject Headings

15 March 2018

0 references

0 references

Sulpiride

0 references

Identifiers

InChI

1 reference

sulpiride (English)

19 November 2016

2 references

sulpiride (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

15676-16-1

2 references

sulpiride (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=15676-16-1

9 April 2021

1 reference

SULPIRIDE (English)

19 November 2016

2 references

sulpiride (English)

19 November 2016

Reaxys registry number

494008

1 reference

sulpiride (English)

3 October 2016

mapping relation type

2 references

SULPIRIDE (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)

1 reference

SULPIRIDE (English)

19 November 2016

2 references

inferred from InChIKey

MSBNK-Athens_Univ-AU168502

1 reference

MassBank accession ID

0 references

MSBNK-Athens_Univ-AU168503

0 references

MSBNK-Athens_Univ-AU168504

0 references

MSBNK-Athens_Univ-AU168505

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-Waters-WA002019

0 references

MSBNK-Waters-WA002020

0 references

MSBNK-Waters-WA002021

0 references

MSBNK-Waters-WA002022

0 references

MSBNK-Waters-WA002023

0 references

SPLASH

splash10-01ox-0049000000-eaadc21e5bafdd34a66e

0 references

splash10-03di-0090000000-16b776d58e4e2dbc163e

0 references

splash10-03di-0090000000-9fda88d7482dee887457

0 references

splash10-0006-0009000000-338379e29df68a5396b7

0 references

splash10-0006-0209000000-d61c87359158078fa846

0 references

splash10-03di-2931000000-6a28d0dd33433a572e50

0 references

splash10-03di-4940000000-dcee56e4387108740566

0 references

splash10-03di-8960000000-9f1a7605079446735287

0 references

splash10-03e9-9620000000-c3bb475e828d5f8c88aa

0 references

splash10-0006-0109000000-838e3fc396f400ef6f4b

0 references

splash10-0a4i-2901000000-15575a206ad43d931d6a

0 references

splash10-0a4i-3900000000-b83b6287d83301602f00

0 references

splash10-0a6r-8900000000-5a447dc363e7b3d43351

0 references

splash10-004i-9200000000-0a29790b32c5ae5e192a

0 references

splash10-004i-9000000000-32eb95f9c75cc8d8ee85

0 references

NMRShiftDB structure ID

20037386

1 reference

DSSTox substance ID

DTXSID1042574

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

1 reference

sulpiride (English)

ECHA Substance Infocard ID

19 November 2016

100.036.124

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Sulpiride (English)

CAS no.: 15676-16-1 (English)

1 reference

Sulpiride (English)

publication date

17 November 2015

1 reference

D02.455.426.559.389.127.085.866

sulpiride (English)

19 November 2016

Sulpiride

0 references

MeSH tree code

D02.065.277.866

0 references

D02.241.223.100.100.866

0 references

0 references

RxNorm ID

10239

1 reference

sulpiride (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0014535

2 references

based on heuristic

inferred from InChIKey

2 references

sulpiride (English)

19 November 2016

PatientsLikeMe treatment ID

0 references

0 references

1 reference

1 reference